1951 - 1975 of 9134 Results
Title
Year
- Lowering the risk of Parkinson’s disease with GLP-1 agonists and DPP4 inhibitors in type 2 diabetes2020OPENTitle: Lowering the risk of Parkinson’s disease with GLP-1 agonists and DPP4 inhibitors in type 2 diabetesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 10Start Page: 2868End Page: 2871Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa287Best OA location URL: https://academic.oup.com/brain/article-pdf/143/10/2868/34032411/awaa287.pdfCitation Count: 14
-
OPENTitle: Feedforward activation of PRKN/parkinJournal Name: AutophagyPublisher: Informa UK LimitedVol: 19Issue #: 2Start Page: 729End Page: 730Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15548627.2022.2100615Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9851250Citation Count: 9
-
OPENTitle: A harmonized segmentation protocol for hippocampal and parahippocampal subregions: Why do we need one and what are the key goals?Journal Name: HippocampusPublisher: WileyVol: 27Issue #: 1Start Page: 3End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hipo.22671Best OA location URL: https://archive-ouverte.unige.ch/unige:111733Citation Count: 181
- Over‐expression of an inactive mutant cathepsin D increases endogenous alpha‐synuclein and cathepsin B activity in SH‐SY5Y cells2013RESTRICTEDTitle: Over‐expression of an inactive mutant cathepsin D increases endogenous alpha‐synuclein and cathepsin B activity in SH‐SY5Y cellsJournal Name: Journal of NeurochemistryPublisher: WileyVol: 128Issue #: 6Start Page: 950End Page: 961Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.12497Citation Count: 40
-
OPENTitle: Multiple sclerosis subgroups: Data-driven clusters based on patient-reported outcomes and a large clinical sampleJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 30Issue #: 13Start Page: 1642End Page: 1652Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/13524585241282763Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11568927/pdf/nihms-2019447.pdfCitation Count: 3
-
OPENTitle: DAT-SPECT-based subtype and stage inference in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-026-01347-2Best OA location URL: https://www.nature.com/articles/s41531-026-01347-2_reference.pdfCitation Count: 1
-
OPENTitle: Structure–Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1H-indoles as Tauopathy Positron Emission Tomography RadiotracersJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 68Issue #: 6Start Page: 6462End Page: 6492Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acs.jmedchem.4c02988Best OA location URL: https://doi.org/10.1021/acs.jmedchem.4c02988Citation Count: 4
- Psychotropic medication usage in sporadic versus genetic behavioral‐variant frontotemporal dementia2024OPENTitle: Psychotropic medication usage in sporadic versus genetic behavioral‐variant frontotemporal dementiaJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 2Start Page: e14448End Page: e14448Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14448Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.14448Citation Count: 1
- Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease2014RESTRICTEDTitle: Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s diseaseJournal Name: NeurosciencePublisher: Elsevier BVVol: 265Issue #:Start Page: 245End Page: 252Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.01.042Citation Count: 37
-
OPENTitle: Reinforcing properties of Pramipexole in normal and parkinsonian ratsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 49Issue #:Start Page: 79End Page: 86Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2012.08.005Best OA location URL: https://doaj.org/article/f2c79dbe00db45cd8b639599d5d6db7fCitation Count: 37
-
OPENTitle: Identifying gait differences between Alzheimer's disease and dementia with Lewy bodies and their associations with regional amyloid depositionJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 2Start Page: e14351End Page: e14351Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14351Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.14351Citation Count: 5
-
OPENTitle: Transcriptomic responses of lung mesenchymal cells during pneumoniaJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 10Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.177084Best OA location URL: https://doi.org/10.1172/jci.insight.177084Citation Count: 3
-
OPENTitle: Clinical and anatomical predictors for freezing of gait and falls after subthalamic deep brain stimulation in Parkinson's disease patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 91End Page: 97Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.021Best OA location URL: http://www.prd-journal.com/article/S1353802019300215/pdfCitation Count: 55
-
OPENTitle: Alzheimer's disease‐associated CD83(+) microglia are linked with increased immunoglobulin G4 and human cytomegalovirus in the gut, vagal nerve, and brainJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 1Start Page: e14401End Page: e14401Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.14401Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.14401Citation Count: 16
-
OPENTitle: Improving Dysarthric Speech Segmentation With Emulated and Synthetic AugmentationJournal Name: IEEE Journal of Translational Engineering in Health and MedicinePublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 12Issue #:Start Page: 382End Page: 389Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1109/jtehm.2024.3375323Best OA location URL: https://ieeexplore.ieee.org/ielx7/6221039/6563131/10464345.pdfCitation Count: 14
-
OPENTitle: Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharideJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 108Issue #:Start Page: 115End Page: 127Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.08.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5734673Citation Count: 74
- Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriers2013RESTRICTEDTitle: Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriersJournal Name: CortexPublisher: Elsevier BVVol: 49Issue #: 9Start Page: 2501End Page: 2511Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cortex.2012.12.017Citation Count: 45
-
OPENTitle: Substantia nigra hyperechogenicity with LRRK2 G2019S mutationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 5Start Page: 885End Page: 888Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23644Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3082617Citation Count: 37
- Abnormalities on structural MRI associate with faster disease progression in multiple system atrophy2018RESTRICTEDTitle: Abnormalities on structural MRI associate with faster disease progression in multiple system atrophyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 58Issue #:Start Page: 23End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.08.004Citation Count: 24
-
OPENTitle: Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patientsJournal Name: Toxicology ReportsPublisher: Elsevier BVVol: 4Issue #:Start Page: 188End Page: 193Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.toxrep.2017.03.005Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S221475001730015X-fx1_lrg.jpgCitation Count: 29
-
OPENTitle: A History of Senile Plaques: From Alzheimer to Amyloid ImagingJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 81Issue #: 6Start Page: 387End Page: 413Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlac030Best OA location URL: https://academic.oup.com/jnen/article-pdf/81/6/387/43778548/nlac030.pdfCitation Count: 33
- The impact of non-motor symptoms on physical activity in Parkinson’s disease2025OPENTitle: The impact of non-motor symptoms on physical activity in Parkinson’s diseaseJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol:Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/17582024.2025.2607694Citation Count: 1
-
OPENTitle: Progressive Decline in Gray and White Matter Integrity in de novo Parkinson’s Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging DataJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page: 318End Page: 318Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2018.00318Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2018.00318/pdfCitation Count: 92
-
OPENTitle: A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 2Start Page: 329End Page: 332Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27259Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27259Citation Count: 20
-
OPENTitle: Dual κ‐agonist/μ‐antagonist opioid receptor modulation reduces levodopa‐induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model ofParkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 77Issue #: 6Start Page: 930End Page: 941Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24375Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6235675Citation Count: 51
